Transdermal skin patches market is anticipated to grow at a significant CAGR during the forecast period. Transdermal patches deliver drugs by adhering to the skin. They are absorbed through the skin and directed into the bloodstream. These patches support to provide a specific, predetermined dose of medication. The major factor driving the market growth is the new product launches across the globe.
For instance, in September 2021, ImQuest Biosciences has announced the launch of an antiretroviral (ARV) transdermal delivery patch. This patch was developed to replace oral medication for HIV patients. Additionally, in December 2020, Agile Therapeutics Inc. announced the launch of Twirla (Levonorgestrel and Ethinyl Estradiol) transdermal system, a new non-daily, non-invasive contraceptive patch, in the US. It is used by women of reproductive potential that has a body mass index (BMI) <30 kg/m2 for whom a combined hormonal contraceptive is appropriate to prevent pregnancy.
Some major players in the market include Teva Pharmaceuticals Industries Ltd, Novartis International AG, Mylan NV, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2021, Luye Pharma announced that it has received approval for Rivastigmine Multi-Day Transdermal Patch by the UK’s Medicines and Healthcare Products Regulatory Agency. It is used for the treatment of mild to moderate dementia associated with Alzheimer’s disease.
To Request a Sample of our Report on Transdermal Skin Patches Market: https://www.omrglobal.com/request-sample/transdermal-skin-patches-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Teva Pharmaceuticals Industries Ltd, Novartis International AG, Mylan NV, among others.
Transdermal Skin Patches Market Report by Segment
By Type
- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Matrix
- Other Types
By Application
- Pain Relief
- Smoking Reduction and Cessation Aid
- Overactive Bladder
- Hormonal Therapy
- Other
A full Report of Transdermal Skin Patches Market is Available @ https://www.omrglobal.com/industry-reports/transdermal-skin-patches-market
Transdermal Skin Patches Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
